ACM
VCYT icon

Atika Capital Management’s Veracyte VCYT Stock Holding History

Atika Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-145,000
Closed -$3.48M – 90
2019
Q3 		$3.48M Buy
145,000
+8,000
+6% +$213K 0.73% 49
2019
Q2 		$3.9M Buy
+137,000
New +$3.42M 0.77% 56
2014
Q3 		– Sell
-112,500
Closed -$1.93M – 74
2014
Q2 		$1.93M Buy
112,500
+11,300
+11% +$163K 1.57% 30
2014
Q1 		$1.73M Buy
101,200
+15,975
+19% +$255K 1.48% 29
2013
Q4 		$1.24M Buy
+85,225
New +$1.11M 1.1% 38

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Atika Capital Management's VCYT Position: Q4 2019 in Review

Atika Capital Management sold out of Veracyte (VCYT) in Q4 2019, closing a stake of 145,000 shares — an estimated $3.48M sold.

Atika Capital Management first reported a position in VCYT in Q4 2013 and held it in 5 quarters. The position peaked at $3.9M in Q2 2019. 179 funds tracked by Wall St. Rank hold VCYT as of Q4 2019.

  • Atika Capital Management reported no remaining Veracyte position as of Q4 2019 after selling out during the quarter.
  • Atika Capital Management sold 145,000 Veracyte shares in Q4 2019, an estimated $3.48M.
  • Atika Capital Management first reported a position in Veracyte in Q4 2013 and held it in 5 quarters.
  • Atika Capital Management's Veracyte position peaked at $3.9M in Q2 2019.
  • 179 funds tracked by Wall St. Rank held Veracyte as of Q4 2019.

Based on Atika Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.